Carlos V. Paya's most recent trade in Vaxcyte Inc was a trade of 15,372 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 4,591 | - | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 19,582 | 19,582 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Carlos V. Paya | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 7,250 | 0 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,500 | 5,625 | - | 0 | Common Stock | |
| Vaxcyte Inc | Carlos V. Paya | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 2,500 | 1,550 | - | 0 | Common Stock | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,550 | 4,050 | - | 0 | Common Stock | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 2,500 | 5,625 | - | 0 | Common Stock | |
| Standard BioTools Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 42,571 | 42,571 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 30,914 | 100,468 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,125 | 3,125 | - | 0 | Common Stock | |
| Vaxcyte Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 15,402 | 15,402 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Carlos V. Paya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 10,342 | 69,554 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Carlos V. Paya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 2,500 | 59,212 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Carlos V. Paya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 2,500 | 0 | - | - | Restricted Stock Units |